SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ashim, S.
Right arrow Articles by Anderson, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ashim, S.
Right arrow Articles by Anderson, I. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Management of diabetes mellitus occurring during treatment with olanzapine: report of six cases and clinical implications

S. Ashim

Department of Psychiatry, Rawnsley Building, Manchester Royal Infirmary, Manchester, UK.

S. Warrington

Cromwell House, Bolton, Salford and Trafford Mental Health NHS Trust, Eccles, Salford, UK.

I. M. Anderson

Neuroscience and Psychiatry Unit, University of Manchester, Stopford Building, Manchester, UK. ian.anderson{at}man.ac.uk

In spite of conflicting reports, there is emerging evidence that at least two of the atypical antipsychotics, clozapine and olanzapine, are associated with an increased risk of developing glucose dysregulation or new onset diabetes mellitus. We report on the management of six patients who developed diabetes mellitus following treatment with olanzapine, five of whom had independent risk factors for diabetes. Olanzapine was changed to quetiapine in all patients with improvement in glycaemic control in two patients. In view of the uncertainty of the size and mechanism of the link between olanzapine and diabetes, we discuss issues surrounding routine clinical management and monitoring of patients on antipsychotics and the clinical implications.

Key Words: adverse drug reaction • antipsychotics • diabetes mellitus • glucose • monitoring • olanzapine

Journal of Psychopharmacology, Vol. 18, No. 1, 128-132 (2004)
DOI: 10.1177/0269881104040253
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J PsychopharmacolHome page
F.-G. B. Pajonk, A. K. Schwertner, and M. A. Seelig
Rapid dose titration of quetiapine for the treatment of acute schizophrenia and acute mania: a case series
J Psychopharmacol, January 1, 2006; 20(1): 119 - 124.
[Abstract] [PDF]


Advertisement